Cargando…
CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells
CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to CD44v6 positive tumor cells with highly efficient anticancer and antimetastatic properties. The reported modular synthesis and facile preparation makes this system highly potent for dev...
Autores principales: | Li, Linxian, Schmitt, Mark, Matzke‐Ogi, Alexandra, Wadhwani, Parvesh, Orian‐Rousseau, Veronique, Levkin, Pavel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238741/ https://www.ncbi.nlm.nih.gov/pubmed/28105395 http://dx.doi.org/10.1002/advs.201600202 |
Ejemplares similares
-
Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
por: Li, Linxian, et al.
Publicado: (2017) -
Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6
por: Volz, Yvonne, et al.
Publicado: (2015) -
c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice
por: Olaku, Vivienne, et al.
Publicado: (2011) -
CD44 regulates Wnt signaling at the level of LRP6
por: Orian-Rousseau, Véronique, et al.
Publicado: (2015) -
Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets
por: Hartmans, Elmire, et al.
Publicado: (2017)